FARRAGUT PARTNERS LLP

Lobbying for PHARMACOSMOS THERAPEUTICS INC. · Pharmaceutical Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · posted Apr 20, 2026

Lobbying activity 1

Health Issues

General representation and issues related to coverage of treatments for chemotherapy induced iron deficiency anemia and chemotherapy induced Myelosuppression

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.